Ahearn Matthew Fraser 4
4 · SHOULDER INNOVATIONS, INC. · Filed Sep 15, 2025
Insider Transaction Report
Form 4
Ahearn Matthew Fraser
DirectorChief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2025-09-11$0.93/sh+12,286$11,486→ 120,320 total - Exercise/Conversion
Stock Option
2025-09-11−12,286→ 0 totalExercise: $0.93Exp: 2027-10-23→ Common Stock (12,286 underlying) - Exercise/Conversion
Common Stock
2025-09-11$2.10/sh+78,616$164,999→ 198,936 total - Exercise/Conversion
Common Stock
2025-09-11$2.48/sh+16,443$40,785→ 215,379 total - Exercise/Conversion
Stock Option
2025-09-11−78,616→ 0 totalExercise: $2.10Exp: 2030-12-16→ Common Stock (78,616 underlying) - Exercise/Conversion
Stock Option
2025-09-11−16,443→ 16,285 totalExercise: $2.48Exp: 2033-05-09→ Common Stock (16,443 underlying)
Footnotes (2)
- [F1]The stock option is fully vested and currently exercisable.
- [F2]The stock option vested as to one-fourth of the underlying shares on April 19, 2024, and the remaining shares vest in 36 equal increments on the last day of each calendar month thereafter.